Trial Profile
A multicentre, observational registry study to evaluate whether bivalirudin is associated with lower mortality than heparin in real world primary PCI.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Myocardial infarction
- Focus Therapeutic Use
- 27 Oct 2015 New trial record
- 29 Aug 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology